COLUMBUS, Ohio--(BUSINESS WIRE)--Sovaldi, the hepatitis C wonder drug, sells for $84,000 in the U.S. but for only $83 in Egypt, says the British tabloid the Daily Mail. The newspaper also reports Egyptian entrepreneurs are providing round-trip air fare to Egypt, a five day tour of the countryside and a Sovaldi cure for $7,000 to foreigners.
In 2014, Gilead Sciences agreed to make Sovaldi available for about $900 per treatment to Egypt. Whether it’s $83 or $900, U.S. consumers and taxpayers are heavily subsidizing the treatment of hundreds of thousands of hepatitis C sufferers in Egypt while in the U.S. Sovaldi’s price tag has forced Medicaid and private insurers to ration the drug, making it available only to persons in the final stages of the potentially deadly liver disease.
Background on Ohio Ballot Issue 2
The Yes on Issue 2 campaign is a broad-based, bi-partisan coalition. More than 200,000 Ohio voters signed petitions to put an amendment on the ballot in November that will lower drug prices for over 4 million Ohioans, including 164,000 children, save taxpayers $400 million annually, reduce healthcare costs for everyone and teach greedy drug companies and their CEOs a lesson.
Paid for by Ohio Taxpayers for Lower Drug Prices